Institutional investors purchased a net $17.1 million shares of TXMD during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 66.11% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 3.9 Million shares of TherapeuticsMD Inc
FRANKLIN ADVISERS, INC. Bought 2.4 Million shares of TherapeuticsMD Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.4 Million shares of TherapeuticsMD Inc